comparemela.com

Latest Breaking News On - Praxis precision medicines company profile - Page 2 : comparemela.com

Jefferies Financial Group Increases Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $128.00

Jefferies Financial Group Increases Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $128.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Praxis-precision-medicines-company-profile
Vr-adviser
Praxis-precision-medicines-inc
Jefferies-financial-group
Sphera-funds-management
Praxis-precision-medicines
Get-free-report
Financial-group
Precision-medicines
Praxis-precision
Asset-management

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Short Interest Update

Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 3,460,000 shares, a growth of 25.4% from the October 31st total of 2,760,000 shares. Based on an average trading volume of 737,900 shares, the short-interest […]

Jill-desimone
Sphera-funds-management
Praxis-precision-medicines-inc
Nasdaq
Praxis-precision-medicines-company-profile
Vr-adviser
Praxis-precision-medicines
Get-free-report
Praxis-precision
Director-jill-desimone
Asset-management
Capital-partners

Malvern Bancorp (NASDAQ:MLVF) Earns Hold Rating from Analysts at StockNews.com

Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) has been given an average recommendation of “Moderate Buy” by the three ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target […]

United-states
America
William-blair
Marcio-souza
Securities-exchange-commission
Praxis-precision-medicines-company-profile
Nasdaq
America-corp
Great-point-partners
Jefferies-financial-group
Praxis-precision-medicines-inc
Praxis-precision-medicines

Short Interest in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Increases By 34.2%

Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 5,970,000 shares, an increase of 34.2% from the March 15th total of 4,450,000 shares. Approximately 14.4% of the company’s shares are sold short. […]

Texas
United-states
William-blair
Marcio-souza
Allspring-global-investments-holdings
Group-plc
Nasdaq
Praxis-precision-medicines-inc
Praxis-precision-medicines-company-profile
Securities-exchange-commission
Barclays-plc
Praxis-precision-medicines

Praxis Precision Medicines' (PRAX) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Praxis Precision Medicines (NASDAQ:PRAX – Get Rating) in a research report sent to investors on Friday morning, Benzinga reports. HC Wainwright currently has a $16.00 price objective on the stock. Separately, William Blair lowered shares of Praxis Precision Medicines from an outperform rating to a market […]

Los-angeles
California
United-states
William-blair
Marcio-souza
Nasdaq
Thrivent-financial-for-lutherans
Securities-exchange-commission
Allspring-global-investments-holdings
Praxis-precision-medicines-inc
Praxis-precision-medicines-company-profile
Los-angeles-capital-management

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.